ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,307 | -22.7% | 3,010 | 0.0% | 0.00% | – |
| Q2 2023 | $138,851 | +15.0% | 3,010 | 0.0% | 0.00% | – |
| Q1 2023 | $120,701 | -13.4% | 3,010 | 0.0% | 0.00% | – |
| Q4 2022 | $139,453 | +11.6% | 3,010 | 0.0% | 0.00% | – |
| Q3 2022 | $125,000 | -30.6% | 3,010 | 0.0% | 0.00% | – |
| Q2 2022 | $180,000 | -17.8% | 3,010 | 0.0% | 0.00% | – |
| Q1 2022 | $219,000 | -54.7% | 3,010 | -47.6% | 0.00% | -100.0% |
| Q4 2021 | $483,000 | -51.7% | 5,743 | -48.3% | 0.00% | 0.0% |
| Q3 2021 | $1,001,000 | +447.0% | 11,102 | +477.6% | 0.00% | – |
| Q2 2021 | $183,000 | +6.4% | 1,922 | +27.3% | 0.00% | – |
| Q1 2021 | $172,000 | +17100.0% | 1,510 | +15000.0% | 0.00% | – |
| Q4 2020 | $1,000 | -99.8% | 10 | -99.8% | 0.00% | -100.0% |
| Q3 2020 | $502,000 | -68.1% | 6,110 | -69.6% | 0.00% | -66.7% |
| Q2 2020 | $1,572,000 | +71.8% | 20,100 | -2.4% | 0.00% | +50.0% |
| Q1 2020 | $915,000 | +4.0% | 20,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $880,000 | +68.6% | 20,600 | +68.9% | 0.00% | +100.0% |
| Q3 2019 | $522,000 | -55.3% | 12,196 | -33.7% | 0.00% | -50.0% |
| Q2 2019 | $1,168,000 | +300.0% | 18,400 | +192.1% | 0.00% | +100.0% |
| Q4 2017 | $292,000 | -11.5% | 6,300 | +1.6% | 0.00% | 0.0% |
| Q3 2017 | $330,000 | -6.2% | 6,200 | +24.0% | 0.00% | 0.0% |
| Q4 2016 | $352,000 | -21.3% | 5,000 | -20.6% | 0.00% | -50.0% |
| Q3 2016 | $447,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |